As announced in today’s Webinar, LUPUS EUROPE is offering new opportunities for people living with lupus to volunteer and support the cause. Specifically, we are looking for 6 new members for our Patient Advisory Network, and 6 more to create a new Lupus Communication Group.

PATIENT ADVISORY NETWORK (PAN)
The PAN is a network of people having lupus that structurally connects the patient community to the scientific community. There has been a sea change in research with stakeholders such as pharmaceuticals, healthcare professionals and academics embracing the value of the lived experience. People with lupus can offer a unique perspective to research bringing personal insights to enable the process to be more relevant, feasible and make outcome measures more meaningful.

Become a PAN member to really make a difference to the lives of people affected by lupus and play a vital role in research! Get involved in a whole range of research activities; be part of the design process,  help develop research questions, apply for funding and ethical approval, sit on an advisory group, carry out the research, help deliver more effective outcome measures, disseminate the research findings & more.
Being in PAN is

a great way to; learn new skills or develop existing skills, get work experience, build your confidence, feel motivated, gain a sense of achievement, contribute to a sector that matters to you, reap the rewards of improving the lives of others with lupus, make new friends and have fun

No previous experience is necessary, you just need a passion, good communication skills, good organisational skills, a willingness to learn, the ability to commit time with us.

We are looking for a wide cross section of applicants of approx. 6 new PAN members with different types of lupus whether it be young or old and any age in between, renal involvement, skin conditions, APS or other areas of involvement, different levels of severity and a good mix geographically of countries.

 

COMMUNICATION GROUP:
Lupus EUROPE’s 3rd Strategic objective is about having a voice and being proactive to bring about change. In order to achieve this, we want to step up our communication skills and effectiveness. Our ambition is to have a true Lupus Europe Comm’s group that brings continuity in support of LUPUS EUROPE’s communication. .
Hence, we are looking for 6-8 people with skills and experience in complementary facets of communication : communication strategy, graphics, WordPress,  writing, fact-checking, proof reading, press kit preparation and more who, who are  available to support LUPUS EUROPE throughout the year.
The selected team will meet face to face so that it can be fully equipped with Lupus Europe’s key relevant elements of LUPUS EUROPE; our mission, aims, objectives, goals, strategies, priorities, achievements and decision making process so we can improve communication using Newsflash, Blog, Website, social media platforms or other materials.
There will be opportunities for some of the Comm group  to join the convention for the purpose of blogging, tweeting, FaceBooking, writing, interviewing and more.

HOW TO APPLY:
For both groups, as well as for any other offer of volunteer services (like translations or anything else) please send us your information stating which network you are interested in, using this link http://eepurl.com/gbVrYz AND send an email to secretariat@lupus-europe.org. We will then come back to you on next steps.
Please note that the application deadline is very short : send your application by MARCH 15, so that we can promptly complete the selection process.

THE FIRST FACE TO FACE MEETING of  both networks will be held in Belgium May 18 -19, 2019. While we do not pay for volunteer work, we do cover all reasonable expenses such as travel and accommodation, and we are sure that you will find the work very rewarding !

For more details, please contact secretariat@lupus-europe.org

Looking forward to hearing from you!

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons
1 week ago
LUPUS EUROPE

🚨 Call for patients🚨

🔊 INSPIRE SURVEY from the University of Cambridge.

This survey aims to improve the understanding of neurological symptoms in SLE and other rheumatic conditions.

Lupus is a very heterogeneous disease, which means that it affects people of different ethnic backgrounds and gender in different ways.

That is why, to get accurate research results, as many different groups as possible must be represented in the sample.

The INSPIRE survey was launched last year to get the patient experience on the assessment/monitoring of neurological symptoms, but they received very few responses from people from ethnic minorities.

That is why the research team led by Dr Chris Wincup has launched a new survey.

The new INSPIRE survey can be completed by lupus patients or their carers from around the world.

🟣 Please share as much as possible 🟣 in order to get a sample that includes a good proportion of all ethnic groups.

Thank you!

bit.ly/inspire_patients_short
... See MoreSee Less

Comment on Facebook

I did it a second time and no it went good till the end

The survey was demolished.

1 week ago
LUPUS EUROPE

Discoid lupus erythematosus (DLE) is the most common form of chronic cutaneous lupus erythematosus. It is characterised by persistent scaly plaques on the scalp, face, and ears, which can progress to scarring, atrophy, depigmentation, and permanent hair loss in affected hair-bearing areas (Source: DermNet).

This study, published by Prof Marca Mosca et al., describes 2 cases of severe and refractory DLE successfully treated with anifrolumab, a human monoclonal antibody.

Although anifrolumab has been recently approved for the treatment of SLE, data from randomized clinical trials have shown a significant difference in cutaneous response rate in patients treated with anifrolumab from those in the placebo group.

While the effectiveness of this treatment in real life and in different types of skin lesions has yet to be determined, it could represent a new valid opportunity for treating DLE.

jamanetwork.com/journals/jamadermatology/article-abstract/2798967
... See MoreSee Less

Discoid lupus erythematosus (DLE) is the most common form of chronic cutaneous lupus erythematosus. It is characterised by persistent scaly plaques on the scalp, face, and ears, which can progress to scarring, atrophy, depigmentation, and permanent hair loss in affected hair-bearing areas (Source: DermNet). 

This study, published by Prof Marca Mosca et al., describes 2 cases of severe and refractory DLE successfully treated with anifrolumab, a human monoclonal antibody. 

Although anifrolumab has been recently approved for the treatment of SLE, data from randomized clinical trials have shown a significant difference in cutaneous response rate in patients treated with anifrolumab from those in the placebo group. 

While the effectiveness of this treatment in real life and in different types of skin lesions has yet to be determined, it could represent a new valid opportunity for treating DLE.

https://jamanetwork.com/journals/jamadermatology/article-abstract/2798967Image attachmentImage attachment
1 week ago
LUPUS EUROPE

We know some of you missed the great seminar recently delivered by Prof. Laurent Arnaud.

Well, no worries!

You have the chance to see it again, thanks to the European Federation of Internal Medicine (EFIM).

"Challenges in 2023 for Systemic Lupus Erythematosus".

Next 29th of March at 18:00 CET (i.e. Paris time).

Register for free here!

us02web.zoom.us/webinar/register/WN_O5yMwjfgTS29pMKvOZfgZw
... See MoreSee Less

We know some of you missed the great seminar recently delivered by Prof. Laurent Arnaud. 

Well, no worries! 

You have the chance to see it again, thanks to the European Federation of Internal Medicine (EFIM). 

Challenges in 2023 for Systemic Lupus Erythematosus.

Next 29th of March at 18:00 CET (i.e. Paris time).

Register for free here! 

https://us02web.zoom.us/webinar/register/WN_O5yMwjfgTS29pMKvOZfgZwImage attachment
1 week ago
LUPUS EUROPE

Did you miss this ERN RECONNET webinar with Lou Kawka and Prof Laurent Arnaud about #fatigue in #SLE?

Now you have the chance to watch it!!! 😃🙌

www.youtube.com/watch?v=7jc7SiP5BsA
... See MoreSee Less

Did you miss this ERN RECONNET webinar with Lou Kawka and Prof Laurent Arnaud about #fatigue in #SLE? 

Now you have the chance to watch it!!! 😃🙌

https://www.youtube.com/watch?v=7jc7SiP5BsA
LUPUS EUROPE Uniting people with Lupus throughout Europe
Send